|
⚲
|
| Keyboard |
| Maniatis Tom
✚
|
|
|---|---|
| CIK # | 0001586935 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001586935] | |
| 4 | [0001586935] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Maniatis Tom | |
| Acceleron Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2019-01-25 | Grant | 7,500 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2019-01-25 | Grant | 1,250 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2018-03-21 | Option exercise | 18,750 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2018-03-21 | Option exercise | 18,750 | $5.08 | 95,250 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2018-03-01 | Grant | 1,250 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2018-03-01 | Grant | 7,500 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2017-03-02 | Grant | 1,250 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2017-03-02 | Grant | 7,500 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2016-03-03 | Grant | 10,000 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2015-01-08 | Grant | 10,000 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2014-12-08 | Sell | 23,400 | $45.00 | 1,053,000 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2014-10-31 | Sell | 23,400 | $40.00 | 936,000 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2014-10-28 | Sell | 17,872 | $35.00 | 625,520 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2014-10-27 | Sell | 5,528 | $35.00 | 193,480 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2014-08-13 | Gift | 40,000 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2014-06-30 | Sell | 39,439 | $33.87 | 1,335,799 |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2014-06-30 | Sell | 1,561 | $34.41 | 53,714 |
|
Acceleron Pharma Inc XLRN
Option to Purchase Common Stock · derivative
|
2013-12-05 | Grant | 20,000 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Series B Convertible Preferred Stock · derivative
|
2013-09-24 | Conversion | 9,261 | $0.00 | |
|
Acceleron Pharma Inc XLRN
Common Stock
|
2013-09-24 | Conversion | 25,108 | ||
| showing 20 of 26 most recent transactions | |||||